EnglishMyelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. Most MDS are characterized by anemia, and a number of cases progresses to acute myeloid leukemia (AML). Indeed, the molecular mechanisms underlying the MDS evolution to AML are still unclear, even though the nuclear signaling elicited by PI-PLCβ1 has been demonstrated to play an important role in the control of the balance between cell cycle progression and apoptosis in MDS cells. Here we review both the role of epigenetic therapy on PI-PLCβ1 promoter and the changes in PI-PLCβ1 expression in MDS patients treated for anemia.
Myelodysplastic syndromes (MDS), clonal hematopoietic stem-cell disorders mainly affecting older adult patients, show ineffective hematopoiesis in one or more of the lineages of the bone marrow. Most MDS are characterized by anemia, and a number of cases progresses to acute myeloid leukemia (AML). Indeed, the molecular mechanisms underlying the MDS evolution to AML are still unclear, even though the nuclear signaling elicited by PI-PLCβ1 has been demonstrated to play an important role in the control of the balance between cell cycle progression and apoptosis in MDS cells. Here we review both the role of epigenetic therapy on PI-PLCβ1 promoter and the changes in PI-PLCβ1 expression in MDS patients treated for anemia. © 2012 Elsevier Ltd.
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS / Follo, Matilde Y.; Marmiroli, Sandra; Faenza, Irene; Fiume, Roberta; Ramazzotti, Giulia; Martelli, Alberto M.; Gobbi, Pietro; Mccubrey, James A.; Finelli, Carlo; Manzoli, Francesco A.; Cocco, Lucio. - In: ADVANCES IN BIOLOGICAL REGULATION. - ISSN 2212-4926. - STAMPA. - 53:1(2013), pp. 2-7.
| Data di pubblicazione: | 2013 |
| Titolo: | Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. |
| Autore/i: | Follo, Matilde Y.; Marmiroli, Sandra; Faenza, Irene; Fiume, Roberta; Ramazzotti, Giulia; Martelli, Alberto M.; Gobbi, Pietro; Mccubrey, James A.; Finelli, Carlo; Manzoli, Francesco A.; Cocco, Lucio |
| Autore/i UNIMORE: | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.jbior.2012.09.009 |
| Rivista: | |
| Volume: | 53 |
| Fascicolo: | 1 |
| Pagina iniziale: | 2 |
| Pagina finale: | 7 |
| Codice identificativo Scopus: | 2-s2.0-84874007797 |
| Codice identificativo Pubmed: | 23058275 |
| Citazione: | Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS / Follo, Matilde Y.; Marmiroli, Sandra; Faenza, Irene; Fiume, Roberta; Ramazzotti, Giulia; Martelli, Alberto M.; Gobbi, Pietro; Mccubrey, James A.; Finelli, Carlo; Manzoli, Francesco A.; Cocco, Lucio. - In: ADVANCES IN BIOLOGICAL REGULATION. - ISSN 2212-4926. - STAMPA. - 53:1(2013), pp. 2-7. |
| Tipologia | Articolo su rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | |
|---|---|---|---|
| ABR.53 Follo MDS.pdf | articolo principale | Versione dell'editore (versione pubblicata) | Open Access Visualizza/Apri |
http://hdl.handle.net/11380/1149512
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
Copyright © 2021